Skip to main content
. 2017 Nov 13;15(1):1093–1098. doi: 10.3892/etm.2017.5494

Figure 4.

Figure 4.

Transfection with miR-370 mimics suppresses the proliferation of (A) the U-251MG astrocytoma cell line and (B) the U-87MG human glioblastoma cell line. The viability of negative control or miR-370 mimics-transfected cells was determined by an MTT assay at 1, 2, 3, 4 and 5 days. *P<0.05, **P<0.01, compared with negative control group. miR, microRNA; Ctrl., control; d, days.